CVM — CEL SCI CORP

US Healthcare Pharma & biotech equity mkt cap 25.7M
1.42 -2.74% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 0.97 · high 13.04

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day-2.74%
1 week-7.79%
1 month+19.33%
3 months-2.07%
6 months-70.42%
Year to date-72.43%
1 year-84.04%
3 years-96.30%
5 years-99.48%

Technicals

RSI 1457.4
vs 50-day avg+12.77%
vs 200-day avg-60.49%
Volatility 1y112.5%
Max drawdown 1y-92.53%
Avg volume 30d279.3K
Daily bars held2,674
History from2016-01-04

Measured signals that fired on CVM

datesignal measured base rate
2026-05-18Conviction buy by an officer
insider
-1.03% over 21 days · t = -2.24 · n = 1,083
statistically distinguishable from its control group
2026-03-06Short volume far above its own normal
short
-0.76% over 21 days · t = -2.79 · n = 5,897
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-06-30KERSTEN GEERT R
Chief Executive Officer
Grant or award5.2K1.045.4K
2026-06-30PRICHEP PATRICIA B
Chief Financial Officer
Grant or award4.1K1.044.3K
2026-06-30TALOR EYAL
Chief Scientific Officer
Grant or award2.3K1.042.4K
2026-05-14KERSTEN GEERT R
Chief Executive Officer
Open-market purchase300.0K1.20360.0K
2026-05-13KERSTEN GEERT R
Chief Executive Officer
Open-market purchase100.0K1.19119.0K
2026-03-31KERSTEN GEERT R
Chief Executive Officer
Grant or award1.7K3.215.4K
2026-03-31PRICHEP PATRICIA B
Chief Financial Officer
Grant or award1.3K3.214.3K
2026-03-31TALOR EYAL
Chief Scientific Officer
Grant or award7473.212.4K
2026-01-22KERSTEN GEERT R
Chief Executive Officer
Open-market purchase38.0K5.26200.0K
2025-12-31KERSTEN GEERT R
Chief Executive Officer
Grant or award9985.265.2K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
VANGUARD CAPITAL MANAGEMENT LLC782.1K243.6K
MAI Capital Management293.0K91.3K
GEODE CAPITAL MANAGEMENT, LLC274.0K85.3K
VANGUARD FIDUCIARY TRUST CO157.4K49.0K
BlackRock, Inc.138.9K43.3K
BANK OF AMERICA CORP /DE/131.6K41.0K
RENAISSANCE TECHNOLOGIES LLC115.2K35.9K
US BANCORP \DE\96.0K29.9K
STATE STREET CORP87.5K27.3K
XTX Topco Ltd72.4K22.6K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
10-Q2026-08-142026-06-30on EDGAR ↗
ARS2026-07-022025-09-30on EDGAR ↗
DEF 14A2026-07-022026-06-23on EDGAR ↗
42026-07-012026-06-30on EDGAR ↗
42026-07-012026-06-30on EDGAR ↗
42026-07-012026-06-30on EDGAR ↗
8-K2026-06-162026-06-14on EDGAR ↗
424B52026-06-15on EDGAR ↗

Short selling

Avg short volume, 90d44.0% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about CVM

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open CVM in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →